The Valuation Trap: Why a Higher Valuation Can Hurt Founders

The Reflex: Higher Is Better

Few numbers are celebrated as much in the startup ecosystem as the pre-money valuation – and that is understandable. A high valuation means less dilution, greater perceived standing, and a strong signal to talent, the media and future investors.
The problem: A valuation is not a seal of approval, but a promise. It does not describe what a company is worth today, but what it needs to be worth in a few years for the investment made in the current funding round to pay off. If that promise is overly ambitious, the problem is merely pushed into the future – often to exactly the point when fresh capital is needed most.

The Driver Is Often Sitting at the Table

The pressure to aim for a high valuation often comes from existing investors or an overheated market. But the founders’ own mindset is frequently part of the problem.
For many founders, the valuation has long become more than a financial metric: It has become an informal measure of their own success, a validation of their vision and, at times, even a status symbol among fellow founders, their own team or their family.
This emotional attachment makes it difficult to turn down a high valuation during negotiations, even when the analysis suggests that the number goes beyond what the company can realistically be worth in the foreseeable future.
When founders define themselves by their valuation, they ultimately stop negotiating for the company and start negotiating for their own ego – and that is rarely a good starting point for a sustainable capital structure.

How Success Turns into a Trap – The Rollercoaster

An inflated valuation rarely arises from bad intentions. It is often the result of a competitive fundraising process in which several investors are competing for a stake in the company, or of a growth story based on highly optimistic assumptions.
This is exactly where the risk lies: When the next funding round comes around, the market no longer measures the company against its narrative, but against its actual performance – revenue growth, customer retention and unit economics.
If the company falls short of the expectations implied by its previous valuation, it finds itself in an uncomfortable position – and the actual trap snaps shut: the down round.

• The down round as the biggest single risk. A follow-on round at a lower valuation than the previous round is rarely just a number on the term sheet. It sends a clear negative signal, can trigger anti-dilution provisions from earlier agreements and, in the worst case, can significantly dilute the founders’ stake. In many cases, a down round is less a symptom of a failed business model than a direct consequence of an overly ambitious previous round. The real damage, in other words, is caused retrospectively by the earlier decision, not by the company’s current performance. The previously straightforward equity story is fundamentally disrupted.
• Existing investors may hesitate. Investors who entered at an overly high valuation have little incentive to confirm that valuation themselves by participating in a lower follow-on round. This can make it more difficult to attract new, independent investors and may further accelerate the path towards a down round.
• Employee equity loses value. Option pools issued on the basis of a high valuation can become effectively worthless in a down round – creating a risk for team motivation and retention.
• Negotiating leverage decreases. When the cash runway is running short and the company’s story has lost momentum, founders negotiate from a weakened position – often on significantly worse terms than would have been possible with a realistic valuation from the outset.

  A valuation is not a trophy; it is a bar you have to clear again in the next funding round. Set it no higher – and perhaps even with some headroom – than what you can realistically justify through the growth you expect to achieve over the next 18 to 24 months.

What Makes a “Healthy” Valuation?

Rather than aiming for the highest possible number, founders should seek a valuation that best fits their actual growth story. Three questions can help:

Can the next funding round be plausibly justified?
A good valuation is one that allows the company to reach realistic value inflection points over the coming months – milestones that can justify a higher valuation in the subsequent funding round.

How much dilution is actually being avoided?
The difference between an ambitious and a slightly inflated valuation may only amount to a few percentage points of dilution. The difference between a solid valuation and a significantly inflated one, however, can ultimately determine the company’s ability to survive.

Are the investors a good fit for the valuation?
If a valuation is primarily driven by competition between investors, founders should ask themselves whether those investors will still stand firmly behind the company if the numbers do not go exactly according to plan.

Our Perspective at bmp

As an investor supporting companies across multiple funding rounds, we see valuation not as a one-off negotiation outcome, but as part of a long-term capital strategy.
A valuation that reflects the company’s actual stage of development and a realistic growth plan creates the foundation for the ability to raise follow-on financing – round after round.
The goal for every startup should be to raise capital as smoothly as possible and avoid down rounds. A healthy valuation protects founders, the team and existing investors alike from unpleasant surprises when the market becomes less euphoric than it was at the time of the last term sheet.
A startup’s success is not reflected in the highest number on its cap table, but in whether enough funding rounds follow to give the company the time and capital it needs to become sustainable.
Ultimately, the smartest valuation is the one you do not have to explain later.

An article by Malte Lindigkeit, Investment Analyst at bmp Ventures.